InvestorsHub Logo
Followers 2
Posts 15
Boards Moderated 0
Alias Born 05/18/2020

Re: Awhit post# 100030

Thursday, 07/30/2020 7:32:44 AM

Thursday, July 30, 2020 7:32:44 AM

Post# of 233384
Kodiak has less than 50 million shares outstanding, CYDY has over 500 million shares outstanding. Anyone thinking we will see a run up to $50/share on efficacy results is only setting up for failure. Realistically we will see a run up in the $10-20 range on results, probably settling around $12-15 within a day or 2. If and that is a big if the FDA grants an EUA then we could see $20-$35 per share.

The only way we would see $50 a share on COVID alone would be if the US government said they would buy all of CYDY's 2020 and 2021 stock (for what Nader projected $7.5 billion). $50 share is about 3X earnings on $7.5 Bil.

That's a lot of if's, and everything going perfectly. From past history everything going perfectly is highly unlikely.

Extreme views of $50-$100 per share on COVID alone is just as bad as those who say the stock is going to $.50.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News